REG-BARCLAYS PLC Form 8.3 - WILLIS TOWERS WATSON PLC
24/03/2021 12:35
For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20210324:nBwbH2LKwa&default-theme=true
Form 8.3 - WILLIS TOWERS WATSON PLC
FORM 8.3
IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER
RULES, 2013
DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR
MORE
1. KEY INFORMATION
Name of person dealing (Note 1) Barclays PLC.
Company dealt in WILLIS TOWERS WATSON PLC
Class of relevant security to which the dealings being disclosed relate (Note ORD
2)
Date of dealing 23 March 2021
2. INTERESTS AND SHORT POSITIONS
(a) Interests and short positions (following dealing) in the class of relevant
security dealt in (Note 3)
Class of relevant security: ORD
Long Short
Number (%) Number (%)
(1) Relevant securities
1,790,295 1.39% 189,753 0.15%
(2) Derivatives (other than options):
102,935 0.08% 7,066 0.01%
(3) Options and agreements to
purchase/sell: 6,100 0.00% 6,100 0.00%
TOTAL:
1,899,330 1.47% 202,919 0.16%
(b) Interests and short positions in relevant securities of the company, other
than the class dealt in (Note 3)
Class of relevant security: Long Short
Number (%) Number (%)
(1) Relevant securities
(2) Derivatives (other than options)
(3) Options and agreements to purchase/sell
Total
Ap20
3. DEALINGS (Note 4)
(a) Purchases and sales
Purchase/sale Number of relevant securities Price per unit
Purchase 1 221.5000 USD
Purchase 1 222.5100 USD
Purchase 19 221.8800 USD
Purchase 33 222.2400 USD
Purchase 100 223.0400 USD
Purchase 100 223.1300 USD
Purchase 100 222.2300 USD
Purchase 200 222.2475 USD
Purchase 246 221.8085 USD
Purchase 300 221.1418 USD
Purchase 392 221.4400 USD
Purchase 400 221.5075 USD
Purchase 478 222.3896 USD
Purchase 1,855 221.4876 USD
Purchase 2,066 221.7052 USD
Purchase 2,600 221.9823 USD
Purchase 6,687 222.0402 USD
Purchase 7,378 222.0485 USD
Purchase 9,042 221.9501 USD
Purchase 9,323 221.4884 USD
Purchase 12,078 221.4900 USD
Purchase 20,883 221.8603 USD
Purchase 22,091 221.7520 USD
Sale 4 221.8162 USD
Sale 19 221.8800 USD
Sale 23 222.0000 USD
Sale 100 220.7600 USD
Sale 100 222.3900 USD
Sale 100 222.4100 USD
Sale 109 221.7002 USD
Sale 176 221.9900 USD
Sale 200 221.5550 USD
Sale 200 222.2475 USD
Sale 200 222.1000 USD
Sale 201 222.0966 USD
Sale 203 221.8750 USD
Sale 246 221.8085 USD
Sale 300 222.0400 USD
Sale 300 221.9016 USD
Sale 300 222.0383 USD
Sale 311 221.8509 USD
Sale 400 221.8418 USD
Sale 467 221.9105 USD
Sale 496 222.0079 USD
Sale 500 222.3220 USD
Sale 500 221.6670 USD
Sale 597 222.0792 USD
Sale 828 221.9800 USD
Sale 869 221.4512 USD
Sale 900 222.0972 USD
Sale 1,747 221.8118 USD
Sale 1,854 221.4875 USD
Sale 2,100 221.9457 USD
Sale 2,238 221.6645 USD
Sale 6,777 222.0593 USD
Sale 6,860 221.9788 USD
Sale 7,563 222.0558 USD
Sale 8,993 222.0725 USD
Sale 10,821 222.0292 USD
Sale 11,603 221.5220 USD
Sale 26,807 221.4900 USD
(b) Derivatives transactions (other than options transactions)
Product name, Nature of transaction Number of relevant securities Price per unit
e.g. CFD (Note 6) (Note 7) (Note 5)
(c) Options transactions in respect of existing relevant securities
(i) Writing, selling, purchasing or varying
Product name, Writing, selling, purchasing, varying etc. Number of securities to which the option relates (Note 7) Exercise price Type, e.g. American, European etc. Expiry date Option money paid/received per unit (Note 5)
e.g. call option
(ii) Exercising
Product name, Number of securities Exercise price per unit (Note 5)
e.g. call option
(d) Other dealings (including transactions in respect of new securities) (Note
4)
Nature of transaction Details Price per unit
(Note 8) (if applicable) (Note 5)
Ap21
2. OTHER INFORMATION
Agreements, arrangements or understandings relating to options or derivatives
Full details of any agreement, arrangement or understanding between the person
disclosing and any other person relating to the voting rights of any relevant
securities under any option referred to on this form or relating to the voting
rights or future acquisition or disposal of any relevant securities to which
any derivative referred to on this form is referenced. If none, this should be
stated.
None
Is a Supplemental Form 8 attached? (Note 9) YES
Date of disclosure 24 March 2021
Contact name Large Holdings Regulatory Operations
Telephone number 020 3134 7213
If a connected EFM, name of offeree/offeror with which connected
If a connected EFM, state nature of connection (Note 10)
Ap23
SUPPLEMENTAL FORM 8
IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 8.1 AND RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997,
TAKEOVER RULES, 2013
DETAILS OF OPEN POSITIONS
(This form should be attached to Form 8.1(a) & (b)(i), Form 8.1(b)(ii) or
Form 8.3, as appropriate)
OPEN POSITIONS (Note 1)
Product name Written or Number of Exercise Type Expiry
purchased relevant securities price date
to which the option
or derivative
relates
Put Options Purchased -100 220.0000 American Jul 16, 2021
Call Options Purchased 100 240.0000 American Jul 16, 2021
Call Options Purchased 6,000 220.0000 American Jul 16, 2021
Put Options Purchased -6,000 200.0000 American Jul 16, 2021
Notes
1. Where there are open option positions or open derivative positions (except
for CFDs), full details should be given. Full details of any existing
agreements to purchase or to sell must also be given on this form.
2. For all prices and other monetary amounts, the currency must be stated.
For full details of disclosure requirements, see Rule 8 of the Rules. If in
doubt, consult the Panel.
View source version on businesswire.com:
https://www.businesswire.com/news/home/20210324005533/en/
(https://www.businesswire.com/news/home/20210324005533/en/)
BARCLAYS PLC
Copyright Business Wire 2021Recent news on Barclays
See all newsREG - Entain PLC Barclays PLC - TR1: Notification of Major Holdings
AnnouncementREG - Gym Group PLC (The) Barclays PLC - Holding(s) in Company
AnnouncementREG - Barclays PLC British Land Co PLC - Form 8.3 BRITISH LAND COMPANY PLC, THE
AnnouncementREG - Barclays PLC Spire Healthcare Grp - Form 8.3 SPIRE HEALTHCARE GROUP PLC
AnnouncementREG - Barclays PLC NCC Group PLC - Form 8.3 NCC GROUP PLC
Announcement